Although activation of HER2 leads to several proliferative or apoptotic signaling pathways, including MAPK, PI3K/AKT, and JAK/STAT, its oncogenic and tumorigenic roles have been clearly illustrated in different cancers [170]. Here, AKT1 is linked to cancer.